.png "Merit Medical Systems (NASDAQ: MMSI)")
Barrington analyst Michael Petusky maintained a Buy rating on Merit Medical Systems (MMSI) today and set a price target of $59. The company’s shares opened today at $44, close to its 52-week low of $39.72.
Petusky commented:
“We are currently modeling non-GAAP EPS of $1.75 on revenue of $1.014 billion in FY/19.”
According to TipRanks.com, Petusky is a 4-star analyst with an average return of 4.9% and a 52.0% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Varian Medical Systems, and DENTSPLY SIRONA Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Merit Medical Systems with a $58.75 average price target, implying a 33.5% upside from current levels. In a report released today, Piper Jaffray also maintained a Buy rating on the stock with a $58 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $66.34 and a one-year low of $39.72. Currently, Merit Medical Systems has an average volume of 370.4K.
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is neutral on the stock. Last month, Justin Lampropoulos, the EVP GLOBAL SALES, MKTG & STGY of MMSI sold 8,000 shares for a total of $486,880.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Merit Medical Systems, Inc. engages in the manufacture and market of proprietary disposable medical devices. It operates through Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups.
